0.28Open0.28Pre Close0 Volume3 Open Interest60.00Strike Price0.00Turnover194.83%IV25.57%PremiumDec 27, 2024Expiry Date0.00Intrinsic Value100Multiplier3DDays to Expiry0.28Extrinsic Value100Contract SizeAmericanOptions Type-0.0441Delta0.0065Gamma286.57Leverage Ratio-0.1821Theta-0.0003Rho-12.65Eff Leverage0.0069Vega
DexCom Stock Discussion
Revenue came in at $994.2 million, topping the forecast of $990.71 million and showing growth from last year's $975 million.
The company announced that Teri Lawver, EVP and Chief Commercial Officer, will retire by year-end, with CEO Kevin Sayer temporarily leading the commercial team.
DexCom reaffirmed its 2024 sales outl...
No comment yet